Bioptimus, a global AI company building the world's first world model for biology, today announced the launch of its Spatial ...

William Blair upgraded 10x Genomics Inc. TXG stock, citing it as the best-in-class technology and is well-positioned to ...

Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling CareDx will ...

Psomagen, a recognized leader in servicing academic and commercial clients, will serve as a partner, introduce OmicInsight’s specialized spatial transcriptomics services to its extensive network ...

With a trio of partnership announcements this month, 10x Genomics has signaled it is looking beyond its traditional focus on research tools for academic, government, and industry customers, by ...

Spatial transcriptomics is a technique that provides information about gene expression patterns within intact tissues. This technology employs various methodologies, including in situ sequencing (ISS) ...

Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling CareDx, Inc.

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, ...

SANTA CLARA, CA, UNITED STATES, January 20, 2026 /EINPresswire.com/ — OmicInsight Corporation, an innovator in AI-powered spatial biology and high-resolution ...